Oncoinvent ASA Company Description

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer.

Its lead product candidate is Radspherin, alpha-radiation therapy candidate designed for the direct targeting of cancers that have spread to body cavities, like the peritoneum in two phase 1/2a trials and one randomized phase 2 trial.

The company was incorporated in 2010 and is based in Oslo, Norway.

Oncoinvent ASA

Country	Norway
Founded	2010
Industry	Biological Products, Except Diagnostic Substances
Employees	34
CEO	Oystein Soug

Contact Details

Address: Gullhaugveien 7 Oslo, 0484 Norway
Phone	47 22 18 33 05
Website	oncoinvent.com

Stock Details

Ticker Symbol	ONCIN
Exchange	Oslo Børs
Fiscal Year	January - December
Reporting Currency	NOK
SIC Code	2836

Key Executives

Name	Position
Oystein Soug	Chief Executive Officer
Tore Kvam	Chief Financial Officer
Gro Hjellum	Chief Operating Officer